An Internal Control for Routine Diagnostic PCR: Design, Properties, and Effect on Clinical Performance
- 1 January 1998
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 36 (1) , 191-197
Abstract
We constructed internal controls (ICs) to provide assurance that clinical specimens are successfully amplified and detected. The IC nucleic acids contain primer binding regions identical to those of the target sequence and contain a unique probe binding region that differentiates the IC from amplified target nucleic acid. Because only 20 copies of the IC are introduced into each test sample, a positive IC signal indicates that amplification was sufficient to generate a positive signal from targets present at the limit of test sensitivity. The COBAS AMPLICOR Chlamydia trachomatis , Neisseria gonorrhoeae , Mycobacterium tuberculosis , and human hepatitis C virus tests exhibited inhibition rates ranging from 5 to 9%. Approximately 64% of these inhibitory specimens were not inhibitory when a second aliquot was tested. Because repeatedly inhibitory specimens were not reported as false negative and because additional infected specimens were detected during retesting, test sensitivities were 1 to 6% greater than they would have been if the IC had not been used.Keywords
This publication has 26 references indexed in Scilit:
- Sensitivity of ligase chain reaction assay of urine from pregnant women for Chlamydia trachomatisThe Lancet, 1997
- Comparison of DNA Amplification Methods for the Detection of Chlamydia trachomatis in First-Void Urine From Asymptomatic Military RecruitsSexually Transmitted Diseases, 1996
- Diagnosis Of Chlamydia Trachomatis Urethral Infection In Symptomatic And Asymptomatic Men By Testing First-Void Urine In A Ligase Chain Reaction AssayThe Journal of Infectious Diseases, 1994
- Polymerase Chain Reaction in Infectious Disease DiagnosisLaboratory Medicine, 1994
- Diagnosis of Male Chlamydia trachomatis Urethritis by Polymerase Chain ReactionSexually Transmitted Diseases, 1994
- The Polymerase Chain Reaction: Clinical Applications1992
- Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction.Proceedings of the National Academy of Sciences, 1990
- Quantitation of HIV-1 proviral DNA relative to cellular DNA by the polymerase chain reactionAnalytical Biochemistry, 1990
- Quantitation of mRNA by the polymerase chain reaction.Proceedings of the National Academy of Sciences, 1989
- Specific amplification of a DNA sequence common to all Chlamydia trachomatis serovars using the polymerase chain reactionResearch in Microbiology, 1989